Tatva Chintan Pharma Chem Limited (TATVA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) has a cash flow conversion efficiency ratio of 0.019x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs135.54 Million ≈ $1.47 Million USD) by net assets (Rs7.27 Billion ≈ $78.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tatva Chintan Pharma Chem Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Tatva Chintan Pharma Chem Limited - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Tatva Chintan Pharma Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tatva Chintan Pharma Chem Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tatva Chintan Pharma Chem Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Leysen Jewellery Inc
SHG:603900
|
0.027x |
|
Ritek Corp
TW:2349
|
-0.009x |
|
T3EX Global Holdings Corp
TW:2636
|
-0.023x |
|
Funko Inc
NASDAQ:FNKO
|
0.060x |
|
E Split Corp Class A
TO:ENS
|
0.100x |
|
Iljin HySolus Co Ltd
KO:271940
|
0.008x |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
0.038x |
|
Arvind SmartSpaces Limited
NSE:ARVSMART
|
0.168x |
Annual Cash Flow Conversion Efficiency for Tatva Chintan Pharma Chem Limited (2018–2025)
The table below shows the annual cash flow conversion efficiency of Tatva Chintan Pharma Chem Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see TATVA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs7.39 Billion ≈ $79.90 Million |
Rs246.71 Million ≈ $2.67 Million |
0.033x | -74.90% |
| 2024-03-31 | Rs7.37 Billion ≈ $79.71 Million |
Rs980.44 Million ≈ $10.60 Million |
0.133x | +146.47% |
| 2023-03-31 | Rs5.15 Billion ≈ $55.67 Million |
Rs277.83 Million ≈ $3.00 Million |
0.054x | +25.29% |
| 2022-03-31 | Rs4.73 Billion ≈ $51.16 Million |
Rs203.78 Million ≈ $2.20 Million |
0.043x | -70.60% |
| 2021-03-31 | Rs1.66 Billion ≈ $17.95 Million |
Rs243.19 Million ≈ $2.63 Million |
0.147x | -31.87% |
| 2020-03-31 | Rs1.18 Billion ≈ $12.73 Million |
Rs253.12 Million ≈ $2.74 Million |
0.215x | +133.02% |
| 2019-03-31 | Rs797.00 Million ≈ $8.62 Million |
Rs73.56 Million ≈ $795.52K |
0.092x | -47.56% |
| 2018-03-31 | Rs591.56 Million ≈ $6.40 Million |
Rs104.12 Million ≈ $1.13 Million |
0.176x | -- |
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more